Podcast

MIB Agents OsteoBites and osTEAo

Each week, MIB Agents talks with the leaders and innovators in osteosarcoma surgery, research, treatment and advocacy. Questions are taken during the webinar and are included in each podcast. More…

Download on the App Store

Already have it? Open in the app

Latest episodes

  1. Combinatorial immunotherapy to overcome cellular therapy resistance in osteosarcoma3 Aug 2026
  2. Epigenetic Regulation of the Type I Interferon Pathway in Osteosarcoma: Implications for Immune Checkpoint Blockade24 Jul 2026
  3. osTEAo: Live from FACTOR '26!16 Jul 2026
  4. osTEAo: Advocacy Doesn't End at Discharge18 Jun 2026
  5. A Guide to FACTOR 2026 Scientific Panels29 May 2026
  6. osTEAo - More Than Physical: The Mental Toll of Cancer22 May 2026
  7. A Phase 1/2, Study to Evaluate LNTH-2403, a LRRC15-targeted radiopharmaceutical, in Patients with Relapsed/Refractory Osteosarcoma15 May 2026
  8. Defining tumor-specific vulnerabilities by mapping oncogenic structural variation in osteosarcoma8 May 2026
  9. Targeting Perioperative Myeloid Responses Through NOD/RIPK2 Modulation to Prevent Metastatic Progression in Osteosarcoma24 Apr 2026
  10. Zanzalintinib in Osteosarcoma: Balancing Disease Control and Quality of Life10 Apr 2026